How EMA PRAC Evaluates Emerging Drug Safety Signals

Understanding the Evaluation Process of Drug Safety Signals by EMA PRAC Key Takeaways EMA PRAC plays a pivotal role in the identification and evaluation of drug safety signals across Europe. Regular data review and stakeholder collaboration are crucial for effective signal detection. Understanding regulatory frameworks enhances compliance and inspection readiness…

Key Pharmacovigilance Learnings from EMA PRAC June 2026 Meeting

Insights and Learnings from the June 2026 EMA PRAC Meeting Key Takeaways Increased focus on real-world data for pharmacovigilance assessments. Emphasis on the importance of timely reporting and data integrity. New guidelines on risk management plans and signal detection processes. Enhanced collaboration with stakeholders to improve patient safety. Recommendations for…